Top Cities for Rheumatic Diseases Clinical Trials
Rheumatic Diseases clinical trials are recruiting across 10 cities. Here are the cities with the most active studies:
About Rheumatic Diseases
Rheumatic diseases encompass over 200 conditions affecting joints, bones, muscles, and connective tissues. They include arthritis, lupus, fibromyalgia, and many others. Treatment varies by specific condition but often involves anti-inflammatory medications, DMARDs, and biologics.
Clinical trials are advancing new treatments for rheumatic diseases. Currently, 1 studies are recruiting a combined 400 participants across the United States. Research is being conducted by 1 organizations including Boehringer Ingelheim.
2026 Rheumatic Diseases Research Landscape
As of March 2026, the rheumatic diseases clinical trial landscape includes 1 actively recruiting studies across 10 cities in the United States. These studies are collectively seeking 400 participants, with an average enrollment target of 400 per study.
Research is being led by 1 organization, including Boehringer Ingelheim.
Geographically, rheumatic diseases trials are most concentrated in Birmingham, Alabama (1 trial); Scottsdale, Arizona (1 trial); Los Angeles, California (1 trial); San Diego, California (1 trial); Denver, Colorado (1 trial) and 5 other cities.
Featured Rheumatic Diseases Studies
Highlighted recruiting studies for rheumatic diseases, selected by enrollment size and research scope.
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study. People can only take part if they show no improvement in lung function after standard treatment with immunosuppressant medicine. The main purpose of this study is to find out how a medicine called nerandomilast affects the lungs in people with syste...
Frequently Asked Questions About Rheumatic Diseases Clinical Trials
Are there rheumatic diseases clinical trials near me?
Yes, there are 1 rheumatic diseases clinical trials currently recruiting across 10+ cities in the United States, including Birmingham, Alabama; Scottsdale, Arizona; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a rheumatic diseases clinical trial?
To join a rheumatic diseases clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are rheumatic diseases clinical trials free?
Yes, participation in rheumatic diseases clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of rheumatic diseases treatments are being studied?
Current rheumatic diseases clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in rheumatic diseases clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov